Concepedia
Statistics
Publications
18
Citations
945
H-Index
15
Active since
2012
Affiliations
Novo Nordisk (Denmark)(Current)
University of Cambridge
Aarhus University
École Polytechnique Fédérale de Lausanne
Novo Nordisk (Switzerland)
Nikolai Lorenzen is an author at Novo Nordisk (Denmark) specializing in pharmacy, monoclonal antibodies, and antibody engineering.
Publications per year
2012–2024
The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Nikolai Lorenzen, Søren B. Nielsen, Alexander K. Buell et al. · Journal of the American Chemical Society · 2014 · 257 citations
Life Sciences, Biochemistry, Molecular Biology +17
In vitro and in silico assessment of the developability of a designed monoclonal antibody library
Adriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen et al. · mAbs · 2018 · 101 citations · Full text
Pharmacy, Biotechnology, Immunology +17
Design of Biopharmaceutical Formulations Accelerated by Machine Learning
Harini Narayanan, Fabian Dingfelder, Itzel Condado Morales et al. · Molecular Pharmaceutics · 2021 · 100 citations · Full text
Engineering, Bioengineering, Biotechnology +13
A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice
Jacob Lund, Per Greisen, Stine Kjellev et al. · Blood · 2021 · 85 citations · Full text
Medicine, Hematology, Pathology +14
Automated optimisation of solubility and conformational stability of antibodies and proteins
Angelo Rosace, Anja Bennett, Marc Oeller et al. · Nature Communications · 2023 · 61 citations · Full text
Pharmacy, Bioengineering, Biotechnology +15
1–5 of 18